Dr Randy Jean Guliuzza, MD | |
2900 Doolittle Dr, Ellsworth Afb, SD 57706-4821 | |
(605) 385-3663 | |
Not Available |
Full Name | Dr Randy Jean Guliuzza |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Aerospace Medicine |
Location | 2900 Doolittle Dr, Ellsworth Afb, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1649243486 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083A0100X | Preventive Medicine - Aerospace Medicine | 5978A (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Randy Jean Guliuzza, MD 23888 S Rockerville Rd, Rapid City, SD 57702-7412 Ph: (605) 343-3860 | Dr Randy Jean Guliuzza, MD 2900 Doolittle Dr, Ellsworth Afb, SD 57706-4821 Ph: (605) 385-3663 |
News Archive
University of Minnesota Medical School and Minneapolis VA Medical Center research shows that smokers who receive support over the telephone when trying to quit are more successful in kicking the habit than those who receive help as part of routine medical care.
There are 15 new cases of amyotrophic lateral sclerosis, or ALS, diagnosed in the U.S. each day. The disease causes patients to slowly lose the ability to speak, eat, move and breathe, and comes with an average life expectancy of two to five years after diagnosis.
RTI Health Solutions, a business unit of RTI International, partnered with the U.S. Food and Drug Administration to conduct a study on patients' preferences which contributed to the Agency's regulatory decision to approve the Maestro Rechargeable System, a first-of-kind device to treat obesity.
Medical device company Vertos Medical Inc. has announced the unveiling of 12-week clinical data from its prospective, 75-patient MiDAS I (mild Decompression Alternative to open Surgery) study that further validate the safety and efficacy of mild for the treatment of lumbar spinal stenosis (LSS). Consistent with the positive six-week study results released in March and May, the new MiDAS I data demonstrate that mild patients continued to experience statistically significant improvement in pain, physical function and mobility 12 weeks following treatment.
Aerotel Medical Systems, a leading global vendor of advanced remote patient monitoring solutions, will introduce its HeartOne V, a state-of-the-art, single-lead, handheld ECG device at MEDICA 2016, which will take place November 14-17, 2016 in Dusseldorf, Germany.
› Verified 1 days ago